The report forecasts the global renal denervation market to grow at a CAGR of 11.82% during the period 2016-2020.
Commenting on the report, an analyst from the research team said: Increase in M&A will be a key trend for market growth. Vendors present in the market are undergoing M&A to expand their global presence, mitigate the loss of patent protection, expand their product portfolio, and achieve economies of scale.
For instance, Boston Scientific acquired Vessix Vascular, a developer of catheter-based renal denervation systems for treating uncontrolled hypertension, in January 2012. Boston Scientific expects that the Vessix Vascular renal denervation system will help it gain market leadership. These types of M&A will provide substantial synergies for many vendors, including an enviable combination to access a global customer base, as well as complement expansion of product portfolios.
According to the report, widespread prevalence of hypertension will be a key driver for market growth. Unhealthy diet, stress, and physical inactivity can lead to conditions such as hypertension, hypercholesterolemia, coronary artery disease, and diabetes. Hypertension or high blood pressure can cause ischemia and stroke. With each passing year, the prevalence of hypertension is rising worldwide. In 2013, CDC estimated that more than 30% of the global adult population had hypertension.
- What will the market size be in 2020 and what will the growth rate be?
- What are the key market trends?
- What is driving this market?
- What are the challenges to market growth?
- Who are the key vendors in this market space?
- What are the market opportunities and threats faced by the key vendors?
- What are the strengths and weaknesses of the key vendors?
- Boston Scientific
- ReCor Medical
- St Jude Medical
- Kona Medical
- Sound Intervention
PART 01: Executive summary
PART 02: Scope of the report
PART 03: Market research methodology
PART 04: Introduction
PART 05: Impact of SYMPLICITY on global renal denervation market
PART 06: Market landscape
PART 07: Geographical segmentation
PART 08: Market drivers
PART 09: Impact of drivers
PART 10: Market challenges
PART 11: Impact of drivers and challenges
PART 12: Market trends
PART 13: Vendor landscape
PART 14: Appendix
PART 15: About the Author
For more information about this report visit http://www.researchandmarkets.com/research/5nl38x/global_renal
Laura Wood, Senior Manager
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/research-and-markets---global-renal-denervation-market-cagr-growth-of-1182-by-2020---trends-technologies--opportunities-report-2016-2020---key-vendors-st-jude-medical-cardiosonic-kona-medical-300312863.html
SOURCE Research and Markets